Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HKSE:02427's Days Payable is ranked worse than 95.24% of 189
companies
in the Medical Diagnostics & Research industry
Industry Median: 64.8
vs HKSE:02427: 9.70
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guanze Medical Information Industry (Holding) Co Days Payable Chart
Guanze Medical Information Industry (Holding) Co Annual Data
HKSE:02427 vs TMO, DHR, IDXX: Days Payable Comparison
For the Diagnostics & Research subindustry, Guanze Medical Information Industry (Holding) Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guanze Medical Information Industry (Holding) Co Days Payable vs Medical Diagnostics & Research Industry
Guanze Medical Information Industry (Holding) Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guanze Medical Information Industry (Holding) Co (HKSE:02427) has a Days Payable of 9.02 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Guanze Medical Information Industry (Holding) Co and its competitors. This is 84% above median its historical median of 4.91. Over the past decade, Guanze Medical Information Industry (Holding) Co's Days Payable has ranged from 0.62 to 35.18. According to the industry distribution chart, Guanze Medical Information Industry (Holding) Co ranks #180 out of 189 companies in the Medical Diagnostics & Research industry, placing it in the top 95.2%.
Is Guanze Medical Information Industry (Holding) Co's Days Payable too high?
Guanze Medical Information Industry (Holding) Co's current Days Payable of 9.02 is 84% above median its 10-year median of 4.91. Over the past 10 years, this metric has ranged from a low of 0.62 to a high of 35.18. The Medical Diagnostics & Research industry median Days Payable is 64.80. Guanze Medical Information Industry (Holding) Co's value of 9.02 is 86.1% below this industry median. Based on the distribution chart, Guanze Medical Information Industry (Holding) Co ranks #180 out of 189 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Guanze Medical Information Industry (Holding) Co has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Guanze Medical Information Industry (Holding) Co's Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Guanze Medical Information Industry (Holding) Co ranks #180 out of 189 companies for Days Payable. This places Guanze Medical Information Industry (Holding) Co in the lower half of its industry. The industry median Days Payable is 64.80. Guanze Medical Information Industry (Holding) Co's value of 9.02 is 86.1% below this benchmark. Historically, Guanze Medical Information Industry (Holding) Co's own Days Payable has ranged from 0.62 to 35.18 over the past decade. While the company's 10-year median is 4.91 vs. the industry median of 64.80, Guanze Medical Information Industry (Holding) Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 64.80, based on 189 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guanze Medical Information Industry (Holding) Co's current Days Payable of 9.02 is 86.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Guanze Medical Information Industry (Holding) Co and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 64.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guanze Medical Information Industry (Holding) Co's current Days Payable is 9.02, which is 84% above median its own 10-year median of 4.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guanze Medical Information Industry (Holding) Co stock overvalued right now?
Based on GuruFocus' analysis, Guanze Medical Information Industry (Holding) Co (HKSE:02427) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.28, compared to a current price of HK$2.80 — trading 900% above its estimated fair value. The current Days Payable is 9.02, which is 84% above median its 10-year median of 4.91 and 86.1% below the Medical Diagnostics & Research industry median of 64.80. Guanze Medical Information Industry (Holding) Co's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Guanze Medical Information Industry (Holding) Co (HKSE:02427), the current Days Payable is 9.02 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guanze Medical Information Industry (Holding) Co (HKSE:02427) Overvalued in 2026?
Based on GuruFocus' analysis, Guanze Medical Information Industry (Holding) Co stock appears to be overvalued.
The current stock price of HK$2.80 is trading 900% above its estimated GF Value™ of HK$0.28.
GuruFocus considers Guanze Medical Information Industry (Holding) Co to be Significantly Overvalued.
Key valuation signals for HKSE:02427:
Days Payable: 9.02 (84% above median its 10-year median of 4.91)
GF Value™: HK$0.28 vs. price of HK$2.80 (900% above fair value)
Industry Position: 86.1% below the Medical Diagnostics & Research median (#180 of 189)
No single metric tells the full story. See the HKSE:02427 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guanze Medical Information Industry (Holding) Co Business Description
Guanze Medical Information Industry (Holding) Co Ltd is a medical imaging solutions provider, principally engaged in providing medical imaging film products and medical imaging cloud services in Shandong Province. The company generates the majority of its revenue from the PRC.
52GF Score
Get the complete analysis for HKSE:02427
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02427 has been successfully added to your 
